TAVR in the Different Types of Aortic Stenosis

Aortic stenosis (AS) is classified according to gradient into high flow and high gradient (D1), low flow-low gradient with reduced ejection fraction (D2), and paradoxical low flow-low gradient with conserved ejection fraction (D3).

Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

D3 AS is characterized by ≥50% ejection fraction, but with systolic volume index ≤35 ml/min.

Post TAVR evolution of D2 and D3 AS, as regards quality of life, has not been thoroughly looked into by the existing studies. 

This study looked at 634 patients, 328 presenting D1, 76 with D2 and 230 with D3 AS.

Mean age was 77, 60% were men and STS was 6.6%, with no significant differences in comorbidities, except in those with D2 AS, who presented higher incidence of cardiac failure, functional class IV, atrial fibrillation, definite pacemaker implantation, higher need of cardio-defibrillator prior TAVR and lower ejection fraction. 

At 30 days, those with D1 AS showed higher mortality (2.5% vs. 0% vs. 0%, p=0.03 for D1, D2 and D3 AS respectively), with no differences in stroke, major bleeding, or dialysis need. The need for definite pacemaker implantation was higher among D2 AS patients.

Read also: Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring.

After one year followup, there were no significant differences in mortality, stroke, MI, major bleeding, need for pacemaker implantation or readmission. All 3 groups experienced improved functional class and quality of life. D2 AS patients also showed improved ejection fraction. 

Conclusion

Patients with D2 AS experienced significant improvement in ejection fraction and quality of life at 30 days and one year. The need for pacemaker implantation after TAVR was higher than in the other subtypes, while stroke and mortality were lower than expected, which supports the use of TAVR in this high risk group. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Transcatheter Aortic Valve Replacement Improves Quality of Life and Ventricular Function With Low-Flow/Low-Gradient Aortic Stenosis

Reference: Kelley N. Benck , et al. JSCAIhttps://doi.org/10.1016/j.jscai.2023.101266. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...